CN1872846B - Preparation method of dibenzothiazepine* derivatives - Google Patents
Preparation method of dibenzothiazepine* derivatives Download PDFInfo
- Publication number
- CN1872846B CN1872846B CN2006101003178A CN200610100317A CN1872846B CN 1872846 B CN1872846 B CN 1872846B CN 2006101003178 A CN2006101003178 A CN 2006101003178A CN 200610100317 A CN200610100317 A CN 200610100317A CN 1872846 B CN1872846 B CN 1872846B
- Authority
- CN
- China
- Prior art keywords
- derivative
- carboxy
- general formula
- phenylene sulfide
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明提供一种通过使硝基苯衍生物与硫代水杨酸衍生物反应后,将得到的2-硝基-2’-羟基-苯硫醚衍生物还原,使得到的2-氨基-2’-羟基-苯硫醚衍生物脱水缩合,得到可以用作制备作为抗精神病药有用的11-〔4-(2-(2-羟基乙氧基)乙基)〕-1-哌嗪基二苯并硫氮衍生物的初始原料的以二苯并〔b,f〕〔1,4〕硫氮-11-酮为代表的二苯并硫氮衍生物。The present invention provides a kind of 2-amino- Dehydration condensation of 2'-hydroxyl-phenylene sulfide derivatives can be used to prepare 11-[4-(2-(2-hydroxyethoxy)ethyl)]-1-piperazinyl useful as antipsychotics Dibenzothiazepine derivatives represented by dibenzo[b,f][1,4]thiazepine-11-one as starting materials of dibenzothiazepine derivatives.
Description
本申请是申请号为CN200610006965.7(申请日为1999年7月9日)、发明名称为“二苯并硫氮衍生物的制备方法”的中国申请的分案申请,所述中国申请是申请号为CN99816885.8(国际申请日为1999年7月9日)、发明名称为“二苯并硫氮衍生物的制备方法”的进入国家阶段的PCT申请的分案申请。This application is the application number CN200610006965.7 (application date is July 9, 1999), the invention name is "dibenzothiazepine The divisional application of the Chinese application of "Preparation Method of Derivatives", the Chinese application is the application number CN99816885.8 (the international filing date is July 9, 1999), and the invention name is "Dibenzothiazepine A divisional application of the PCT application that entered the national phase.
技术领域technical field
本发明涉及作为药品的中间体有用的二苯并硫氮衍生物的制备方法。本发明特别涉及作为用于制备作为抗精神病药有用的11-〔4-(2-(2-羟基乙氧基)乙基〕-1-哌嗪基二苯并硫氮及其衍生物的中间体有用的下述通式(5)所示二苯并硫氮衍生物的制备方法。The present invention relates to dibenzothiazepine useful as an intermediate of medicines Methods for the preparation of derivatives. In particular, the present invention relates to 11-[4-(2-(2-hydroxyethoxy)ethyl]-1-piperazinyldibenzothiazepines useful in the preparation of antipsychotics. Dibenzothiazepine shown in the following general formula (5) useful for intermediates of derivatives thereof Methods for the preparation of derivatives.
式中,R1、R2、R3、R4、R5、R6、R7和R8可以相同或不同,表示氢原子或可以具有取代基的烷基、烷氧基、烷基羰基、芳基、芳氧基或芳基羰基。In the formula, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 may be the same or different, and represent a hydrogen atom or an alkyl, alkoxy, or alkylcarbonyl group that may have substituents , aryl, aryloxy or arylcarbonyl.
背景技术Background technique
对于上述通式(5)的二苯并硫氮衍生物,在EP-0282236-A1公报中有记载,阐明以这种二苯并硫氮衍生物为原料,能够衍生得到作为抗精神病药有用的11-〔4-(2-(2-羟基乙氧基)乙基〕-1-哌嗪基二苯并硫氮衍生物。也就是说,阐明使通式(5)的二苯并硫氮衍生物的代表化合物二苯并〔b,f〕〔1,4〕硫氮-11酮与氧氯化磷反应,得到11-氯-二苯并硫氮衍生物,接着使哌嗪加成到该11-氯-二苯并硫氮衍生物上,得到11-哌嗪基-二苯并硫氮衍生物,最后使该11-哌嗪基-二苯并硫氮衍生物与2-氯乙氧基乙醇在碱性条件下反应,能够衍生得到上述11-〔4-(2-(2-羟基乙氧基)乙基〕-1-哌嗪基二苯并硫氮衍生物。For the dibenzothiazepine of the above general formula (5) Derivatives are documented in the EP-0282236-A1 bulletin, illustrating that dibenzothiazepine Derivatives are used as raw materials to obtain 11-[4-(2-(2-hydroxyethoxy)ethyl]-1-piperazinyldibenzothiazepine, which is useful as an antipsychotic derivative. That is to say, clarification makes the dibenzothiazepine of general formula (5) The representative compound of derivatives is dibenzo[b,f][1,4]sulfur -11 ketone reacts with phosphorus oxychloride to give 11-chloro-dibenzothiazepine derivative, followed by the addition of piperazine to the 11-chloro-dibenzothiazepine Derivatives, get 11-piperazinyl-dibenzothiazepine derivatives, finally making the 11-piperazinyl-dibenzothiazepine Derivatives react with 2-chloroethoxyethanol under alkaline conditions to obtain the above-mentioned 11-[4-(2-(2-hydroxyethoxy)ethyl]-1-piperazinyldibenzothio nitrogen derivative.
在上述EP-0282236-A1公报中,作为二苯并〔b,f〕〔1,4〕硫氮-11-酮的制备方法,还记载了利用2-(苯硫基)苯基氨基甲酸苯酯或其类似化合物的环化反应(多磷酸存在下)的方法。In the above-mentioned EP-0282236-A1 communique, as dibenzo [b, f] [1,4] sulfur nitrogen - The production method of 11-one also describes a method using a cyclization reaction (in the presence of polyphosphoric acid) of phenyl 2-(phenylthio)phenylcarbamate or its analogues.
Helv.Chim.Acta,42卷,1263页(1959年)记载了使硫代水杨酸甲酯衍生物和2-卤代硝基苯衍生物在钠存在下进行加热反应,合成2-硝基-2’-羧基-苯硫醚衍生物,使用兰尼镍将其还原,制成2-氨基-2’-羧基-苯硫醚衍生物,最后使之在高温下反应,制备二苯并硫氮衍生物的方法。Helv.Chim.Acta, volume 42, page 1263 (1959) records that methyl thiosalicylate derivatives and 2-halogenated nitrobenzene derivatives are heated in the presence of sodium to synthesize 2-nitro -2'-Carboxyl-phenylene sulfide derivatives, which are reduced using Raney nickel to produce 2-amino-2'-carboxy-phenylene sulfide derivatives, which are finally reacted at high temperature to prepare dibenzosulfide nitrogen Derivative method.
Org.Prep.Proced.Int.,287页(1974年)记载了在甲醇钠和铜存在下加热硫代水杨酸酯衍生物与2-碘代硝基苯衍生物后,进行碱和酸处理,合成2-硝基-2’-羧基-苯硫醚衍生物,使用硫酸亚铁的氨水溶液将其还原,制成2-氨基-2’-羧基-苯硫醚衍生物,最后在加热减压条件下使之反应,制备二苯并硫氮衍生物的方法。Org.Prep.Proced.Int., page 287 (1974) describes base and acid treatments after heating thiosalicylate derivatives and 2-iodonitrobenzene derivatives in the presence of sodium methoxide and copper , synthesize 2-nitro-2'-carboxy-phenylene sulfide derivatives, use ferrous sulfate ammonia solution to reduce it to make 2-amino-2'-carboxy-phenylene sulfide derivatives, and finally reduce Make it react under pressure condition, prepare dibenzothiazepine Derivative method.
WO92/19607号公报中记载了使2-氨基苯硫酚和2-氟苯甲腈反应得到2-(2-氨基苯硫基)苯甲腈后,将该化合物水解,制成2-(2-羧基苯硫基)苯胺,最后使该化合物进行环化反应,制备通式(5)的二苯并硫氮衍生物的方法。In the WO92/19607 bulletin, it is described that after 2-aminothiophenol and 2-fluorobenzonitrile are reacted to obtain 2-(2-aminophenylthio) benzonitrile, the compound is hydrolyzed to prepare 2-(2 -carboxyphenylthio) aniline, finally make this compound carry out cyclization reaction, prepare the dibenzothiazepine of general formula (5) Derivative method.
如上所述,作为通式(5)的二苯并硫氮衍生物的制备方法,虽然已知几种方法,但是这些方法存在收率低,需要高温反应,需要使用特殊的原料,或者使用工业后处理麻烦的化合物等作为工业制备方法必须改良的问题。As mentioned above, as dibenzothiazepine of general formula (5) Although several methods are known for the preparation of derivatives, these methods have problems such as low yield, high-temperature reaction, special raw materials, or use of compounds that are troublesome for industrial post-processing, etc., which must be improved as industrial preparation methods.
发明公开invention disclosure
因此,本发明的目的在于提供一种工业上有效制备上述通式(5)的二苯并硫氮衍生物的方法,也就是说,使用容易获得的原料化合物,不进行繁杂的后处理,而且高收率得到所需的二苯并硫氮衍生物的制备方法。Therefore, the object of the present invention is to provide a kind of dibenzothiazepine that effectively prepares above-mentioned general formula (5) industrially Derivatives, that is, using readily available starting compounds, without complicated workup, and obtaining the desired dibenzothiazepines in high yields Methods for the preparation of derivatives.
本发明人为了解决上述课题进行了悉心的研究,结果发现了使用容易获得的硝基苯衍生物和硫代水杨酸衍生物能够高收率而且通过简单操作制备通式(5)的二苯并硫氮衍生物的新型方法,从而完成了本发明。The inventors of the present invention have conducted intensive research in order to solve the above-mentioned problems, and as a result, have found that the diphenylene compound of the general formula (5) can be prepared in high yield and by simple operation using readily available nitrobenzene derivatives and thiosalicylic acid derivatives. And sulfur nitrogen A novel method of derivatives, thus completing the present invention.
本发明涉及下述通式(5)表示的二苯并硫氮衍生物的制备方法,其特征在于使通式(1)表示的硝基苯衍生物与下述通式(2)表示的硫代水杨酸衍生物反应,生成下述通式(3)表示的2-硝基-2’-羧基-苯硫醚衍生物后,将该2-硝基-2’-羧基-苯硫醚衍生物还原,生成下述通式(4)表示的2-氨基-2’-羧基-苯硫醚衍生物后,使该2-氨基-2’-羧基-苯硫醚衍生物脱水缩合。The present invention relates to dibenzothiazepine represented by the following general formula (5) The preparation method of the derivative is characterized in that the nitrobenzene derivative represented by the general formula (1) is reacted with the thiosalicylic acid derivative represented by the following general formula (2) to generate the compound represented by the following general formula (3). After the 2-nitro-2'-carboxy-phenylene sulfide derivatives, the 2-nitro-2'-carboxy-phenylene sulfide derivatives are reduced to generate the 2-amino group represented by the following general formula (4): -2'-carboxy-phenylene sulfide derivative, the 2-amino-2'-carboxy-phenylene sulfide derivative is dehydrated and condensed.
(式中,R1、R2、R3和R4可以相同或不同,表示氢原子或可以具有取代基的烷基、烷氧基、烷基羰基、芳基、芳氧基或芳基羰基,而且X表示卤素原子)(In the formula, R 1 , R 2 , R 3 and R 4 may be the same or different, and represent a hydrogen atom or an alkyl, alkoxy, alkylcarbonyl, aryl, aryloxy or arylcarbonyl group that may have a substituent , and X represents a halogen atom)
(式中,R5、R6、R7和R8可以相同或不同,表示氢原子或可以具有取代基的烷基、烷氧基、烷基羰基、芳基、芳氧基或芳基羰基)(In the formula, R 5 , R 6 , R 7 and R 8 may be the same or different, and represent a hydrogen atom or an alkyl, alkoxy, alkylcarbonyl, aryl, aryloxy or arylcarbonyl group that may have a substituent )
(式中,R1、R2、R3、R4、R5、R6、R7和R8表示与上述相同的含义)(In the formula, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 represent the same meanings as above)
(式中,R1、R2、R3、R4、R5、R6、R7和R8表示与上述相同的含义)(In the formula, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 represent the same meanings as above)
(式中,R1、R2、R3、R4、R5、R6、R7和R8表示与上述相同的含义)(In the formula, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 represent the same meanings as above)
本发明还涉及下述通式(5)表示的二苯并硫氮衍生物的制备方法,其特征在于使下述通式(3)表示的2-硝基-2’-羧基-苯硫醚衍生物还原,生成下述通式(4)表示的2-氨基-2’-羧基-苯硫醚衍生物后,使该2-氨基-2’-羧基-苯硫醚衍生物脱水缩合。The present invention also relates to dibenzothiazepine represented by the following general formula (5) The preparation method of the derivative is characterized in that the 2-nitro-2'-carboxy-phenylene sulfide derivative represented by the following general formula (3) is reduced to generate the 2-amino-sulfide derivative represented by the following general formula (4). After the 2'-carboxy-phenylene sulfide derivative is prepared, the 2-amino-2'-carboxy-phenylene sulfide derivative is dehydrated and condensed.
(式中,R1、R2、R3、R4、R5、R6、R7和R8可以相同或不同,表示氢原子或可以具有取代基的烷基、烷氧基、烷基羰基、芳基、芳氧基或芳基羰基)(In the formula, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 may be the same or different, and represent a hydrogen atom or an alkyl group, an alkoxy group, an alkyl group that may have a substituent carbonyl, aryl, aryloxy or arylcarbonyl)
(式中,R1、R2、R3、R4、R5、R6、R7和R8表示与上述相同的含义)(In the formula, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 represent the same meanings as above)
(式中,R1、R2、R3、R4、R5、R6、R7和R8表示与上述相同的含义)(In the formula, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 represent the same meanings as above)
本发明还涉及上述通式(3)表示的2-硝基-2’-羧基-苯硫醚衍生物。The present invention also relates to 2-nitro-2'-carboxy-phenylene sulfide derivatives represented by the above general formula (3).
本发明通式(5)的二苯并硫氮衍生物的制备方法的各步骤可以用下述反应方案表示。The dibenzothiazepine of general formula (5) of the present invention Each step of the preparation method of the derivative can be represented by the following reaction scheme.
发明的最佳实施方式BEST MODE FOR CARRYING OUT THE INVENTION
本发明的二苯并硫氮衍生物的制备方法涉及的各个通式中,R1至R8表示的“可以具有取代基的烷基”是指不具有取代基的碳原子数1~10个的直链状或支链状烷基,或者具有取代基的碳原子数1~10个的直链状或支链状烷基。Dibenzothiazepine of the present invention In each of the general formulas involved in the preparation method of the derivative, the "alkyl group that may have a substituent" represented by R1 to R8 refers to a straight-chain or branched group having 1 to 10 carbon atoms without a substituent. An alkyl group, or a straight-chain or branched-chain alkyl group having 1 to 10 carbon atoms having a substituent.
作为上述“不具有取代基的碳原子数1~10个的直链状或支链状烷基”,优选碳原子数1~8个(特别是碳原子数1~5个)的直链状或支链状烷基,例如甲基、乙基、丙基(包括异构体)、丁基(包括异构体)、戊基(包括异构体)、己基(包括异构体)、庚基(包括异构体)、辛基(包括异构体)、壬基(包括异构体)、癸基(包括异构体)等,优选甲基、乙基、丙基(包括异构体)、丁基(包括异构体)、戊基(包括异构体)、己基(包括异构体)、庚基(包括异构体)、辛基(包括异构体),特别优选甲基、乙基、丙基(包括异构体)、丁基(包括异构体)、戊基(包括异构体)。As the above-mentioned "straight-chain or branched alkyl group having 1 to 10 carbon atoms having no substituent", a straight-chain alkyl group having 1 to 8 carbon atoms (particularly 1 to 5 carbon atoms) is preferable. Or branched chain alkyl, such as methyl, ethyl, propyl (including isomers), butyl (including isomers), pentyl (including isomers), hexyl (including isomers), heptyl (including isomers), octyl (including isomers), nonyl (including isomers), decyl (including isomers), etc., preferably methyl, ethyl, propyl (including isomers ), butyl (including isomers), pentyl (including isomers), hexyl (including isomers), heptyl (including isomers), octyl (including isomers), particularly preferably methyl , ethyl, propyl (including isomers), butyl (including isomers), pentyl (including isomers).
另外,作为“具有取代基的碳原子数1~10个的直链状或支链状烷基”的烷基部分,例如上述(1)中所述的烷基。In addition, the alkyl moiety of "a linear or branched alkyl group having 1 to 10 carbon atoms having a substituent" includes, for example, the alkyl group described in (1) above.
上述“具有取代基的碳原子数1~10个的直链状或支链状烷基”的取代基可以位于烷基部分的任意位置。作为这种取代基的实例,例如甲氧基、乙氧基、丙氧基(包括异构体)、丁氧基(包括异构体)、戊氧基(包括异构体)、己氧基(包括异构体)、庚氧基(包括异构体)、辛氧基(包括异构体)、壬氧基(包括异构体)、癸氧基(包括异构体)等碳原子数1~10个的直链或支链状烷氧基,乙酰基、丙酰基(包括异构体)、丁酰基(包括异构体)、戊酰基等具有碳原子数1~5个的直链状或支链状烷基部分的碳原子数2~6个的烷基羰基,可以被取代的苯基羰基,或可以被取代的苯基。The substituent of the above-mentioned "linear or branched alkyl group having 1 to 10 carbon atoms having a substituent" may be located at any position of the alkyl moiety. As examples of such substituents, for example, methoxy, ethoxy, propoxy (including isomers), butoxy (including isomers), pentyloxy (including isomers), hexyloxy (including isomers), heptyloxy (including isomers), octyloxy (including isomers), nonyloxy (including isomers), decyloxy (including isomers) and other carbon atoms 1 to 10 straight-chain or branched alkoxy groups, acetyl, propionyl (including isomers), butyryl (including isomers), pentanoyl, etc. have straight chains with 1 to 5 carbon atoms An alkylcarbonyl group having 2 to 6 carbon atoms in a straight or branched alkyl moiety, an optionally substituted phenylcarbonyl group, or an optionally substituted phenyl group.
上述“可以被取代的苯基羰基”是指不具有取代基的苯基羰基或者具有取代基的苯基羰基。“可以被取代的苯基”是指不具有取代基的苯基,或者具有取代基的苯基。作为“具有取代基的苯基羰基”或“具有取代基的苯基”的备取代基,例如苯基、苯基羰基、上述烷基、上述烷氧基或上述烷基羰基。The above-mentioned "phenylcarbonyl group which may be substituted" refers to a phenylcarbonyl group which does not have a substituent or a phenylcarbonyl group which has a substituent. "A phenyl group which may be substituted" means a phenyl group which does not have a substituent, or a phenyl group which has a substituent. As an alternative substituent of "phenylcarbonyl having a substituent" or "phenyl carbon having a substituent", for example, phenyl, phenylcarbonyl, the above-mentioned alkyl, the above-mentioned alkoxy or the above-mentioned alkylcarbonyl.
本发明中,上述通式(2)、(3)、(4)和(5)的R1至R8表示的“可以具有取代基的烷氧基”是指具有不带取代基的碳原子数1~10个的直链状或支链状烷基部分的碳原子数1~10个的烷氧基,或者具有带取代基的碳原子数1~10个的直链状或支链状烷基部分的碳原子数1-10个的烷氧基。In the present invention, the "alkoxy group that may have a substituent" represented by R1 to R8 of the above general formulas (2), (3), (4) and (5) means a carbon atom having no substituent An alkoxy group with 1 to 10 carbon atoms in a linear or branched alkyl moiety having 1 to 10 carbon atoms, or a linear or branched chain with 1 to 10 carbon atoms having a substituent An alkoxy group having 1 to 10 carbon atoms in the alkyl moiety.
作为上述“具有不带取代基的碳原子数1~10个的直链状或支链状烷基部分的碳原子数1~10个的烷氧基”,可以例举上述烷氧基。另外,作为“具有带取代基的碳原子数1~10个的直链状或支链状烷基部分的碳原子数1~10个的烷氧基”的取代基的实例,例如上述烷基、碳原子数2~6个的烷基羰基、可以被取代的苯基羰基和可以被取代的苯基。Examples of the "alkoxy group having 1 to 10 carbon atoms having a linear or branched alkyl moiety having 1 to 10 carbon atoms without a substituent" include the aforementioned alkoxy groups. In addition, examples of the substituent of "an alkoxy group having 1 to 10 carbon atoms having a linear or branched chain alkyl group having a substituent having 1 to 10 carbon atoms" include the above-mentioned alkyl groups , an alkylcarbonyl group having 2 to 6 carbon atoms, an optionally substituted phenylcarbonyl group and an optionally substituted phenyl group.
本发明的二苯并硫氮衍生物的制备方法涉及的各个通式中,R1至R8表示的“可以具有取代基的烷基羰基”是指具有不带取代基的碳原子数1~10个的直链状或支链状烷基部分的碳原子数2~11个的烷基羰基,或者具有带取代基的碳原子数1~10个的直链状或支链状烷基部分的碳原子数2~11个的烷基羰基。Dibenzothiazepine of the present invention In each of the general formulas involved in the preparation method of the derivative, the "alkylcarbonyl group that may have a substituent" represented by R1 to R8 refers to a straight-chain or branched carbon group with 1 to 10 carbon atoms without substituents. An alkylcarbonyl group with 2 to 11 carbon atoms in the chain alkyl part, or a straight-chain or branched chain alkyl part with 2 to 11 carbon atoms in the substituent the alkylcarbonyl.
作为上述“具有不带取代基的碳原子数1~10个的直链状或支链状烷基部分的碳原子数2~11个的烷基羰基”的烷基部分,例如上述烷基。作为“具有带取代基的碳原子数1~10个的直链状或支链状烷基部分的碳原子数2~11个的烷基羰基”的取代基,例如上述烷基的取代基。Examples of the alkyl moiety of the "alkylcarbonyl group having 2 to 11 carbon atoms having a linear or branched chain alkyl moiety having 1 to 10 carbon atoms without substituents" include the above-mentioned alkyl groups. Examples of the substituent of the "alkylcarbonyl group having 2 to 11 carbon atoms having a linear or branched chain alkyl moiety having 1 to 10 carbon atoms with a substituent" include the above-mentioned alkyl substituents.
本发明的二苯并硫氮衍生物的制备方法涉及的各个通式中,R1至R8表示的“可以具有取代基的芳基”是指不具有取代基的芳基,或者具有取代基的芳基。Dibenzothiazepine of the present invention In each general formula involved in the preparation method of the derivative, the "aryl group that may have a substituent" represented by R1 to R8 means an aryl group without a substituent or an aryl group with a substituent.
作为上述“不具有取代基的芳基”例如苯基、萘基、蒽基等,优选苯基、萘基,特别优选苯基。作为“具有取代基的芳基”的取代基,例如上述烷基的取代基。Examples of the above-mentioned "aryl group having no substituent" include phenyl, naphthyl, anthracenyl, etc., preferably phenyl and naphthyl, particularly preferably phenyl. As a substituent of "the aryl group which has a substituent", the substituent of the said alkyl group is mentioned, for example.
本发明的二苯并硫氮衍生物的制备方法涉及的各个通式中,R1至R8表示的“可以具有取代基的芳氧基”是指具有不带取代基的芳基部分的芳氧基,或者具有带取代基的芳基部分的芳氧基。Dibenzothiazepine of the present invention In each general formula involved in the preparation method of the derivative, the "aryloxy group that may have a substituent" represented by R1 to R8 refers to an aryloxy group having an aryl moiety without a substituent, or an aryloxy group having a substituent The aryloxy group of the aryl moiety.
作为上述“具有不带取代基的芳基部分的芳氧基”的芳基,例如上述芳基。而且,作为“具有带取代基的芳基部分的芳氧基”的取代基,例如上述烷基的取代基。As the aryl group of the above-mentioned "aryloxy group having an aryl moiety having no substituent", there may be exemplified the above-mentioned aryl group. Moreover, as a substituent of "aryloxy group which has a substituent aryl moiety", the substituent of the above-mentioned alkyl group is mentioned, for example.
本发明的二苯并硫氮衍生物的制备方法涉及的各个通式中,R1至R8表示的“可以具有取代基的芳基羰基”是指具有不带取代基的芳基部分的芳基羰基,或者具有带取代基的芳基部分的芳基羰基。Dibenzothiazepine of the present invention In each general formula involved in the preparation method of the derivative, the "arylcarbonyl group that may have a substituent" represented by R1 to R8 refers to an arylcarbonyl group having an aryl moiety without a substituent, or an arylcarbonyl group having a substituent The arylcarbonyl of the aryl moiety.
作为上述“具有不带取代基的芳基部分的芳基羰基”的芳基,例如上述芳基。作为“具有带取代基的芳基部分的芳基羰基”的取代基,例如上述烷基的取代基。The aryl group as the above-mentioned "arylcarbonyl group having an aryl moiety having no substituent" includes, for example, the above-mentioned aryl group. As the substituent of the "arylcarbonyl group having a substituted aryl moiety", there may be exemplified the substituents of the above-mentioned alkyl groups.
R1至R8可以相同或不同,优选氢原子、烷基、烷氧基、烷基羰基、芳基、芳氧基或芳基羰基,特别优选氢原子、烷基、烷氧基或烷基羰基。 R1 to R8 can be the same or different, preferably hydrogen atom, alkyl, alkoxy, alkylcarbonyl, aryl, aryloxy or arylcarbonyl, particularly preferably hydrogen atom, alkyl, alkoxy or alkyl carbonyl.
作为通式(1)的X表示的卤素原子,例如氟原子、氯原子、溴原子或碘原子,优选氟原子、氯原子或溴原子。The halogen atom represented by X in the general formula (1) is, for example, a fluorine atom, a chlorine atom, a bromine atom or an iodine atom, preferably a fluorine atom, a chlorine atom or a bromine atom.
其次,对本发明的二苯并硫氮衍生物的制备方法的各步骤进行详细说明。Secondly, to dibenzothiazepine of the present invention Each step of the preparation method of the derivative is described in detail.
在本发明的二苯并硫氮衍生物的制备方法的第1步骤中,优选在碱存在下,在溶剂中,使通式(1)表示的硝基苯衍生物与通式(2)表示的硫代水杨酸衍生物反应,制备通式(3)表示的2-硝基-2’-羧基-苯硫醚衍生物。Dibenzothiazepine in the present invention In the first step of the preparation method of the derivative, preferably in the presence of a base, in a solvent, the nitrobenzene derivative represented by the general formula (1) is reacted with the thiosalicylic acid derivative represented by the general formula (2) , to prepare a 2-nitro-2'-carboxy-phenylene sulfide derivative represented by the general formula (3).
作为上述第1步骤中使用的通式(1)的硝基苯衍生物的具体实例,例如2-氯硝基苯、2-溴硝基苯、2-氟硝基苯、2-碘硝基苯、2-氯-5-甲氧基-硝基苯、2-溴-5-甲氧基-硝基苯、2-氟-5-甲氧基-硝基苯、2-碘-5-甲氧基-硝基苯、2-氯-5-甲基-硝基苯、2-溴-5-甲基-硝基苯、2-氟-5-甲基-硝基苯、2-碘-5-甲基-硝基苯、2-氯-5-苯基-硝基苯、2-溴-5-苯基-硝基苯、2-氟-5-苯基-硝基苯、2-碘-5-苯基-硝基苯、2-氯-5-乙酰基-硝基苯、2-溴-5-乙酰基-硝基苯、2-氟-5-乙酰基-硝基苯以及2-碘-5-乙酰基-硝基苯,优选2-氯硝基苯和2-溴硝基苯。As specific examples of nitrobenzene derivatives of the general formula (1) used in the first step above, for example, 2-chloronitrobenzene, 2-bromonitrobenzene, 2-fluoronitrobenzene, 2-iodonitrobenzene Benzene, 2-chloro-5-methoxy-nitrobenzene, 2-bromo-5-methoxy-nitrobenzene, 2-fluoro-5-methoxy-nitrobenzene, 2-iodo-5- Methoxy-nitrobenzene, 2-chloro-5-methyl-nitrobenzene, 2-bromo-5-methyl-nitrobenzene, 2-fluoro-5-methyl-nitrobenzene, 2-iodo -5-methyl-nitrobenzene, 2-chloro-5-phenyl-nitrobenzene, 2-bromo-5-phenyl-nitrobenzene, 2-fluoro-5-phenyl-nitrobenzene, 2 -iodo-5-phenyl-nitrobenzene, 2-chloro-5-acetyl-nitrobenzene, 2-bromo-5-acetyl-nitrobenzene, 2-fluoro-5-acetyl-nitrobenzene and 2-iodo-5-acetyl-nitrobenzene, preferably 2-chloronitrobenzene and 2-bromonitrobenzene.
作为第1步骤中使用的通式(2)的硫代水杨酸衍生物的具体实例,例如硫代水杨酸、5-甲氧基-硫代水杨酸、5-甲基-硫代水杨酸、5-苯基-硫代水杨酸和5-乙酰基-硫代水杨酸,优选硫代水杨酸和5-甲氧基硫代水杨酸。As specific examples of thiosalicylic acid derivatives of the general formula (2) used in the first step, for example, thiosalicylic acid, 5-methoxy-thiosalicylic acid, 5-methyl-thiosalicylic acid Salicylic acid, 5-phenyl-thiosalicylic acid and 5-acetyl-thiosalicylic acid, preferably thiosalicylic acid and 5-methoxythiosalicylic acid.
通式(1)的硝基苯衍生物相对于通式(2)的硫代水杨酸衍生物1摩尔通常以0.7~10摩尔范围的量使用,特别优选以达到1.0~5倍摩尔比例的用量使用。The nitrobenzene derivative of the general formula (1) is usually used in an amount ranging from 0.7 to 10 moles relative to 1 mole of the thiosalicylic acid derivative of the general formula (2), and is particularly preferably used in a molar ratio of 1.0 to 5 times. Dosage use.
上述第1步骤通常在溶剂的存在下实施。该第1步骤中使用的溶剂只要与反应无关即可,没有特别的限定,例如可以使用水、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、N-甲基吡咯烷酮、二甲基咪唑啉酮等酰胺类有机溶剂,甲醇、乙醇、正丙醇、异丙醇、正丁醇等脂肪族醇类有机溶剂,丙酮、甲基乙基酮、甲基异丁基酮等酮类有机溶剂,乙腈、苯甲腈等腈类有机溶剂。优选水、酰胺类有机溶剂和脂肪族醇类有机溶剂。The first step above is usually carried out in the presence of a solvent. The solvent used in the first step is not particularly limited as long as it has nothing to do with the reaction, for example, water, N,N-dimethylformamide, N,N-dimethylacetamide, N-methylpyrrolidone can be used , dimethyl imidazolinone and other amide organic solvents, methanol, ethanol, n-propanol, isopropanol, n-butanol and other aliphatic alcohol organic solvents, acetone, methyl ethyl ketone, methyl isobutyl ketone Ketone organic solvents such as ketones, nitrile organic solvents such as acetonitrile and benzonitrile. Water, amide-based organic solvents, and aliphatic alcohol-based organic solvents are preferred.
第1步骤的溶剂优选以通式(1)的硝基苯衍生物重量相对于溶剂重量的比“硝基苯衍生物重量/溶剂重量”达到0.05~1.0范围的量使用,特别优选以达到0.1~0.8范围的量使用。The solvent in the first step is preferably used in such an amount that the ratio of the weight of the nitrobenzene derivative of the general formula (1) relative to the weight of the solvent "weight of the nitrobenzene derivative/weight of the solvent" reaches a range of 0.05 to 1.0, particularly preferably 0.1 The amount in the range of ~0.8 is used.
第1步骤的反应温度只要在通常所用溶剂的沸点以下的温度即可,优选0~150℃的范围,特别优选20~100℃的范围。第1步骤的反应时间受反应温度的影响显著,通常在20小时以内结束反应。The reaction temperature in the first step may be a temperature lower than the boiling point of the solvent usually used, and is preferably in the range of 0 to 150°C, particularly preferably in the range of 20 to 100°C. The reaction time of the first step is significantly affected by the reaction temperature, and the reaction is usually completed within 20 hours.
第1步骤的反应通常在碱存在下实施。作为该第1步骤中优选使用的碱,例如碳酸钾、碳酸钠、碳酸锂、氢氧化钠、氢氧化钾、氢氧化锂和甲醇钠,特别优选碳酸钾、碳酸钠、氢氧化钠、氢氧化钾和甲醇钠。这些碱优选以相对于初始原料化合物的总量达到1~10倍摩尔比例的量使用,特别优选使用达到1.5~5倍摩尔比例的量。The reaction in the first step is usually carried out in the presence of a base. As the base preferably used in this first step, for example, potassium carbonate, sodium carbonate, lithium carbonate, sodium hydroxide, potassium hydroxide, lithium hydroxide and sodium methoxide, potassium carbonate, sodium carbonate, sodium hydroxide, hydroxide Potassium and sodium methoxide. These bases are preferably used in an amount of 1 to 10 times the molar ratio of the total amount of the starting material compounds, and particularly preferably used in an amount of 1.5 to 5 times the molar ratio.
实施第1步骤的反应时,除碱以外,也可以进一步加入促进反应的添加物,作为这种添加物,例如碘化钾、N,N-二甲氨基吡啶等。这时添加物的用量优选相对于通式(1)的硝基苯衍生物,按摩尔比达到0.0005~0.5(添加物的摩尔数/硝基苯衍生物的摩尔数)比例的量,特别优选达到0.001~0.1(同样)比例的量。When carrying out the reaction in the first step, in addition to the base, an additive for promoting the reaction may be further added. Examples of such additive include potassium iodide, N,N-dimethylaminopyridine, and the like. At this time, the amount of the additive is preferably an amount that reaches a ratio of 0.0005 to 0.5 (the number of moles of the additive/the number of moles of the nitrobenzene derivative) by molar ratio relative to the nitrobenzene derivative of the general formula (1), particularly preferably The amount to achieve a ratio of 0.001 to 0.1 (same).
本发明制备方法的第1步骤得到的通式(3)的2-硝基-2’-羧基-苯硫醚衍生物的化学结构由通式(1)的硝基苯衍生物的化学结构和通式(2)的硫代水杨酸衍生物的化学结构确定,但作为2-硝基-2’-羧基-苯硫醚衍生物,例如2-硝基-2’-羧基-苯硫醚、2-硝基-4-甲氧基-2’-羧基-苯硫醚、2-硝基-4-甲基-2’-羧基-苯硫醚、2-硝基-4-苯基-2’-羧基-苯硫醚、2-硝基-4-乙酰基-2’-羧基-苯硫醚以及2-硝基-2’-羧基-4’-甲氧基-苯硫醚。优选2-硝基-2’-羧基-苯硫醚以及2-硝基-2’-羧基-4’-甲氧基-苯硫醚。The chemical structure of the 2-nitro-2'-carboxy-phenylene sulfide derivative of the general formula (3) obtained in the first step of the preparation method of the present invention is composed of the chemical structure of the nitrobenzene derivative of the general formula (1) and The chemical structure of the thiosalicylic acid derivatives of general formula (2) is determined, but as 2-nitro-2'-carboxy-phenylene sulfide derivatives, such as 2-nitro-2'-carboxy-phenylene sulfide , 2-nitro-4-methoxy-2'-carboxy-phenylene sulfide, 2-nitro-4-methyl-2'-carboxy-phenylene sulfide, 2-nitro-4-phenyl- 2'-Carboxy-phenylene sulfide, 2-nitro-4-acetyl-2'-carboxy-phenylene sulfide, and 2-nitro-2'-carboxy-4'-methoxy-phenylene sulfide. Preference is given to 2-nitro-2'-carboxy-phenylene sulfide and 2-nitro-2'-carboxy-4'-methoxy-phenylene sulfide.
回收第1步骤生成的通式(3)的2-硝基-2’-羧基-苯硫醚衍生物时,可以将常规的洗涤操作和分离操作组合,利用例如向反应混合物中添加酸使之成为酸性,过滤析出的晶体得到粗产物的方法,或向反应液中添加水和萃取溶剂(有机溶剂),向其中添加酸将水层的pH调节为酸性的方法。另外,也可以通过减压浓缩有机层得到粗产物。通常即使以这样的状态用于以下步骤也没有问题,进一步精制时通过柱色谱法或重结晶操作进行精制即可。关于具体的精制方法最好对各个化合物适当选择。作为上述处理中使用的酸,优选盐酸、硫酸、磷酸和醋酸。When reclaiming the 2-nitro-2'-carboxy-phenylene sulfide derivative of the general formula (3) generated in the first step, conventional washing operations and separation operations can be combined, such as by adding an acid to the reaction mixture to make it It becomes acidic, and the precipitated crystal is filtered to obtain a crude product, or water and an extraction solvent (organic solvent) are added to the reaction liquid, and an acid is added thereto to adjust the pH of the aqueous layer to acidic. Alternatively, the crude product can also be obtained by concentrating the organic layer under reduced pressure. Usually, there is no problem even if it is used in the following steps in such a state, and what is necessary is just to refine|purify by column chromatography or recrystallization operation at the time of further purification. As for the specific purification method, it is preferable to select appropriately for each compound. As the acid used in the above treatment, hydrochloric acid, sulfuric acid, phosphoric acid and acetic acid are preferable.
本发明的制备方法中的第2步骤是通过还原通式(3)的2-硝基-2’-羧基-苯硫醚衍生物,制备通式(4)的2-氨基-2’-羧基-苯硫醚的方法。The second step in the preparation method of the present invention is to prepare the 2-amino-2'-carboxyl of the general formula (4) by reducing the 2-nitro-2'-carboxy-phenylene sulfide derivatives of the general formula (3). - The phenylene sulfide method.
第2步骤中采用的还原操作只要是硝基的一般还原中采用的操作即可,没有特别的限定,优选采用兰尼镍法(以下称为反应(A))、亚铁盐法(以下称为反应(B))或者使用钯或铂或它们的化合物的方法(以下称为反应(C))进行。作为还原反应中氢的供给源,一般使用氢气。The reduction operation adopted in the 2nd step is not particularly limited as long as it is the operation adopted in the general reduction of nitro, preferably adopting Raney nickel method (hereinafter referred to as reaction (A)), ferrous salt method (hereinafter referred to as Reaction (B)) or a method using palladium or platinum or their compounds (hereinafter referred to as reaction (C)). As a supply source of hydrogen in the reduction reaction, hydrogen gas is generally used.
反应(A):兰尼镍法Reaction (A): Raney nickel method
该方法中使用的兰尼镍的用量作为镍量一般相对于通式(3)的2-硝基-2’-羧基-苯硫醚衍生物,通常为1.0~80重量%,优选5.0~40重量%。作为可以利用的兰尼镍的种类,例如10~60%Ni-Al合金。另外,也可以使用作为添加物向其中加入了Cr和Mo的合金。也可以使用稳定化镍。即使改变兰尼镍的展开方法,也不会给收率带来太大的影响,但公知的W-6的方法(参照久保松照夫、小松信一郎,“兰尼催化剂”,川研精细化学株式会社,昭和46年5月10日,55页)获得了最好的结果。当然,即使利用其它展开方法也显示充分的活性。采用兰尼镍法进行反应时,通常在氢加压条件下进行,因此在高压釜中进行。氢压力越高,得到的结果越好,通常在5~100大气压下进行。也可以在常压下进行反应,这时使氢气流通,同时进行反应。The amount of Raney nickel used in this method is generally 1.0 to 80% by weight, preferably 5.0 to 40% by weight relative to the 2-nitro-2'-carboxy-phenylene sulfide derivative of general formula (3) as the nickel amount. weight%. The type of Raney nickel that can be used is, for example, a 10 to 60% Ni—Al alloy. In addition, an alloy to which Cr and Mo are added as additives may also be used. Stabilized nickel may also be used. Even if the development method of Raney nickel is changed, the yield will not be greatly affected, but the known method of W-6 (referring to Kubo Matsuo, Komatsu Shinichiro, "Raney catalyst", Kawaken Fine Chemical Co., Ltd. Club, May 10, Showa 46, page 55) obtained the best results. Of course, sufficient activity was exhibited even with other unfolding methods. When the reaction is carried out by the Raney nickel method, it is usually carried out under hydrogen pressurized conditions, so it is carried out in an autoclave. The higher the hydrogen pressure, the better the results obtained, usually at 5 to 100 atmospheres. The reaction can also be carried out under normal pressure, and in this case, the reaction is carried out while circulating hydrogen gas.
关于反应(A)中使用的溶剂,只要是与反应无关的物质即可,没有特别的限定,优选例如甲醇、乙醇、正丙醇、异丙醇或正丁醇等脂肪族醇类有机溶剂。这些溶剂优选相对于通式(3)的2-硝基-2’-羧基-苯硫醚衍生物的溶剂的比例达到0.05~0.6倍量(2-硝基-2’-羧基-苯硫醚衍生物重量/溶剂的容量)的范围,特别优选达到0.1~0.6倍量(同样)的比例。The solvent used in the reaction (A) is not particularly limited as long as it is irrelevant to the reaction, and is preferably an aliphatic alcohol organic solvent such as methanol, ethanol, n-propanol, isopropanol or n-butanol. The ratio of these solvents preferably reaches 0.05~0.6 times amount with respect to the solvent of the 2-nitro-2'-carboxy-phenylene sulfide derivative of general formula (3) (2-nitro-2'-carboxy-phenylene sulfide Derivative weight/capacity of solvent) is particularly preferably in a ratio of 0.1 to 0.6 times the amount (the same).
作为反应(A)中的反应温度,只要是通常所用溶剂的沸点以下的温度即可,优选20~200℃范围的温度,特别优选25~150℃范围的温度。反应时间受反应温度和氢压力的影响显著,通常在20小时以内结束反应。The reaction temperature in the reaction (A) may be any temperature below the boiling point of the commonly used solvent, and is preferably in the range of 20 to 200°C, particularly preferably in the range of 25 to 150°C. The reaction time is significantly affected by the reaction temperature and hydrogen pressure, and the reaction is usually completed within 20 hours.
通过反应(A)进行还原处理后,生成的通式(4)的2-氨基-2’-羧基-苯硫醚衍生物的回收可以将常规的洗涤操作和分离操作组合,例如过滤反应混合物,将得到的滤液减压浓缩,得到粗产物。通常即使以这种状态用于以下步骤也没有问题,进一步精制时通过柱色谱法或重结晶操作进行精制即可,关于精制方法最好对各个化合物适当选择。After carrying out the reduction treatment by reaction (A), the recovery of the 2-amino-2'-carboxy-phenylene sulfide derivative of the general formula (4) generated can combine conventional washing operations and separation operations, such as filtering the reaction mixture, The obtained filtrate was concentrated under reduced pressure to obtain a crude product. Usually, there is no problem even if it is used in the following steps in this state, and it is sufficient to perform purification by column chromatography or recrystallization operation for further purification, and it is preferable to select an appropriate purification method for each compound.
反应(B):亚铁盐法Reaction (B): ferrous salt method
作为该方法中使用的亚铁盐,例如硫酸亚铁或氯化亚铁,这种亚铁盐能够以水合物或无水物任意一种状态使用。优选硫酸亚铁·7水合物、无水氯化亚铁、氯化亚铁·4水合物以及氯化亚铁·n水合物。这些化合物的用量作为铁原子的量相对于通式(3)的2-硝基-2’-羧基-苯硫醚衍生物为0.1~30倍重量范围内的量,优选0.5~10倍重量范围内的量。As the ferrous salt used in this method, for example, ferrous sulfate or ferrous chloride can be used in any state of hydrate or anhydrate. Preferred are ferrous sulfate heptahydrate, anhydrous ferrous chloride, ferrous chloride tetrahydrate, and ferrous chloride n-hydrate. The amount of these compounds used as the amount of iron atoms relative to the 2-nitro-2'-carboxy-phenylene sulfide derivatives of general formula (3) is the amount within the range of 0.1 to 30 times by weight, preferably 0.5 to 10 times by weight amount within.
作为反应(B)中使用的溶剂,通常使用水和氨水的混合溶剂。使用的氨水通常使用浓氨水(氨浓度为25~28重量%)进行,只要含有的氨量充分,也可以使用更低浓度的氨水,或在水中通入氨气。关于水,优选通式(3)的2-硝基-2’-羧基-苯硫醚衍生物相对于水的量达到0.01~0.4倍当量(2-硝基-2’-羧基-苯硫醚衍生物重量/水的容量)范围的比例,特别优选达到0.02~0.2倍当量(同样)范围的比例。关于氨,2-硝基-2’-羧基-苯硫醚衍生物相对于氨的用量优选达到0.005~0.5倍当量(2-硝基-2’-羧基-苯硫醚衍生物重量/氨的重量)范围的比例,特别优选达到0.01~0.5倍当量(同样)的比例。As the solvent used in the reaction (B), a mixed solvent of water and ammonia water is usually used. The ammonia water used is usually carried out with strong ammonia water (the ammonia concentration is 25-28% by weight), as long as the amount of ammonia contained is sufficient, it is also possible to use lower concentration ammonia water, or feed ammonia gas into the water. Regarding water, the amount of 2-nitro-2'-carboxy-phenylene sulfide derivatives of preferred general formula (3) reaches 0.01~0.4 times equivalent (2-nitro-2'-carboxy-phenylene sulfide) relative to water The ratio in the range of derivative weight/water capacity) is particularly preferably in the range of 0.02 to 0.2 times equivalent (same). Regarding ammonia, the amount of 2-nitro-2'-carboxy-phenylene sulfide derivatives relative to ammonia preferably reaches 0.005 to 0.5 times the equivalent (2-nitro-2'-carboxy-phenylene sulfide derivatives weight/ammonia The ratio in the range of weight) is particularly preferably a ratio of 0.01 to 0.5 times the equivalent (the same).
反应(B)中的反应温度只要是通常所用溶剂的沸点以下的温度即可,优选20~100℃范围的温度,特别优选40~90℃范围的温度。反应时间受反应温度影响显著,通常在2小时以内结束反应。The reaction temperature in reaction (B) should just be the temperature below the boiling point of the solvent normally used, Preferably it is the temperature in the range of 20-100 degreeC, Especially preferably, it is the temperature in the range of 40-90 degreeC. The reaction time is significantly affected by the reaction temperature, and the reaction is usually completed within 2 hours.
通过反应(B)的还原处理后,生成的通式(4)的2-氨基-2’-羧基-苯硫醚衍生物的回收,可以将常规的洗涤操作和分离操作组合,例如可以利用过滤反应混合物,向滤液中添加酸(例如盐酸、硫酸、磷酸、醋酸)将pH调节至酸性侧的方法等进行。另外,通过减压浓缩得到的滤液,可以作为粗产物得到目的化合物。通常即使将这种粗产物用于以下步骤也没有问题,进一步精制时通过柱色谱法或重结晶操作进行精制即可,关于精制方法最好对各个化合物适当选择。After the reduction treatment by reaction (B), the recovery of the 2-amino-2'-carboxy-phenylene sulfide derivatives of the general formula (4) generated can combine conventional washing operations and separation operations, for example, filtration can be used The reaction mixture is carried out by adding an acid (for example, hydrochloric acid, sulfuric acid, phosphoric acid, acetic acid) to the filtrate to adjust the pH to an acidic side, or the like. Alternatively, the obtained filtrate can be concentrated under reduced pressure to obtain the target compound as a crude product. Usually, there is no problem even if such a crude product is used in the following steps. For further purification, it may be purified by column chromatography or recrystallization operation, and it is preferable to select an appropriate purification method for each compound.
反应(C):使用钯或铂(或它们的化合物)的方法Reaction (C): method using palladium or platinum (or their compounds)
该方法中,使用钯(Pd)或铂(Pt)作为还原催化剂(加氢催化剂)。使用的钯或铂可以是钯或铂的单体,也可以是它们的化合物。另外,钯或铂的单体或化合物通常以担载于碳(C)或硫酸钡等载体表面的状态使用。优选Pd/C、Pd/硫酸钡以及氧化铂,特别优选Pd/C。In this method, palladium (Pd) or platinum (Pt) is used as a reduction catalyst (hydrogenation catalyst). The palladium or platinum used may be palladium or platinum alone or a compound thereof. In addition, palladium or platinum alone or compound is usually used in a state supported on the surface of a carrier such as carbon (C) or barium sulfate. Preference is given to Pd/C, Pd/barium sulfate and platinum oxide, with Pd/C being particularly preferred.
含有钯或铂的催化剂的用量相对于通式(3)的2-硝基-2’-羧基-苯硫醚衍生物的用量,按钯或铂单体的重量换算优选达到0.01~30重量%范围的量,特别优选达到0.05~10重量%范围的量。另外,钯或铂相对于催化剂载体的担载量(为钯或铂的化合物的场合,按照各金属的单体重量换算)优选为1~10重量%的范围。另外,使用Pd/C的场合,一般可以使用称为干品的水分含量为5%以下的干燥品,也可以使用水分含量为5%以上的称为湿品的含水品。作为含水品的实例,例如水分含量为10~70重量%(水分量相对于催化剂总体的量的比例)的物质。The amount of the catalyst containing palladium or platinum is preferably 0.01 to 30% by weight in terms of the weight of the palladium or platinum monomer relative to the amount of the 2-nitro-2'-carboxy-phenylene sulfide derivative of the general formula (3). The amount in the range of 0.05 to 10% by weight is particularly preferable. In addition, the supported amount of palladium or platinum on the catalyst carrier (in the case of a compound of palladium or platinum, in terms of the weight of each metal alone) is preferably in the range of 1 to 10% by weight. In addition, when Pd/C is used, it is generally possible to use a dry product with a moisture content of 5% or less called a dry product, or a water-containing product called a wet product with a moisture content of 5% or more. Examples of water-containing products include those having a water content of 10 to 70% by weight (ratio of the water content to the total amount of the catalyst).
反应(C)中,使用氧化铂作为还原催化剂时,氧化铂相对于通式(3)的2-硝基-2’-羧基-苯硫醚衍生物的用量优选达到0.1~50重量%范围的量,特别优选达到1~30重量%范围的量。In reaction (C), when using platinum oxide as a reduction catalyst, the consumption of platinum oxide relative to the 2-nitro-2'-carboxy-phenylene sulfide derivative of general formula (3) preferably reaches 0.1~50% by weight. The amount is particularly preferably in the range of 1 to 30% by weight.
反应(C)通常在氢加压条件下进行。因此,反应通常在高压釜中进行。氢压力越高,得到的结果越好,通常利用2~100大气压的氢加压条件。反应也可以在常压下进行,这时使氢气流通,同时进行还原反应(加氢反应)。Reaction (C) is usually carried out under hydrogen pressure. Therefore, the reaction is usually carried out in an autoclave. The higher the hydrogen pressure, the better the results obtained, typically using hydrogen pressurization conditions of 2 to 100 atmospheres. The reaction can also be carried out under normal pressure. In this case, the hydrogen gas is circulated to carry out the reduction reaction (hydrogenation reaction).
反应(C)通常在溶剂的存在下实施。作为反应(C)中使用的溶剂,只要是与反应无关的物质即可,没有特别的限定,可以使用例如甲醇、乙醇、正丙醇、异丙醇或正丁醇等脂肪族醇类有机溶剂,N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、N-甲基吡咯烷酮或二甲基咪唑啉酮等酰胺类有机溶剂。其中优选脂肪族醇类有机溶剂。这些溶剂相对于通式(3)的2-硝基-2’-羧基-苯硫醚衍生物优选以2~70重量%范围的量使用,特别优选以5~50重量%范围的量使用。Reaction (C) is usually carried out in the presence of a solvent. The solvent used in the reaction (C) is not particularly limited as long as it is irrelevant to the reaction. For example, aliphatic alcohol organic solvents such as methanol, ethanol, n-propanol, isopropanol, or n-butanol can be used. , N,N-dimethylformamide, N,N-dimethylacetamide, N-methylpyrrolidone or dimethylimidazolinone and other amide organic solvents. Among them, aliphatic alcohol organic solvents are preferred. These solvents are preferably used in an amount in the range of 2 to 70% by weight, particularly preferably in an amount in the range of 5 to 50% by weight, based on the 2-nitro-2'-carboxy-phenylene sulfide derivative of the general formula (3).
反应(C)通常在10~200℃的温度范围内实施反应,特别优选利用20~150℃范围的反应温度。另外,反应时间受反应温度和氢压力影响较大,通常利用30小时以内的反应时间。The reaction (C) is usually carried out at a temperature in the range of 10 to 200°C, and it is particularly preferable to use a reaction temperature in the range of 20 to 150°C. In addition, the reaction time is greatly affected by the reaction temperature and hydrogen pressure, and the reaction time within 30 hours is usually used.
采用反应(C)的还原处理(加氢处理)后,生成的通式(4)的2-氨基-2’-羧基-苯硫醚衍生物的回收可以将常规的洗涤操作和分离操作组合,例如可以利用过滤反应混合物,将得到的滤液减压浓缩得到粗产物的方法等进行。通常即使以这种状态用于以下步骤也没有问题,进一步精制时通过柱色谱法或重结晶操作进行精制即可,关于精制方法最好对各个化合物适当选择。After the reduction treatment (hydroprocessing) of reaction (C), the recovery of the 2-amino-2'-carboxy-phenylene sulfide derivative of the general formula (4) generated can combine conventional washing operations and separation operations, For example, it can be carried out by a method of filtering the reaction mixture, concentrating the obtained filtrate under reduced pressure to obtain a crude product, and the like. Usually, there is no problem even if it is used in the following steps in this state, and it is sufficient to perform purification by column chromatography or recrystallization operation for further purification, and it is preferable to select an appropriate purification method for each compound.
本发明的制备方法的第2步骤(还原步骤)得到的通式(4)的2-氨基-2’-羧基-苯硫醚衍生物的化学结构由第2步骤中用作反应原料的通式(3)的2-硝基-2’-羧基-苯硫醚衍生物的化学结构确定。作为通式(4)的2-氨基-2’-羧基-苯硫醚衍生物的实例,例如2-氨基-2’-羧基-苯硫醚、2-氨基-4-甲氧基-2’-羧基-苯硫醚、2-氨基-4-甲基-2’-羧基-苯硫醚、2-氨基-4-苯基-2’-羧基-苯硫醚、2-氨基-4-乙酰基-2’-羧基-苯硫醚以及2-氨基-2’-羧基-4’-甲氧基-苯硫醚。优选2-氨基-2’-羧基-苯硫醚以及2-氨基-2’-羧基-4’-甲氧基-苯硫醚。The chemical structure of the 2-amino-2'-carboxy-phenylene sulfide derivative of the general formula (4) obtained in the 2nd step (reduction step) of the preparation method of the present invention is obtained from the general formula used as the reaction raw material in the 2nd step The chemical structure of the 2-nitro-2'-carboxy-phenylene sulfide derivative of (3) was determined. As examples of 2-amino-2'-carboxy-phenylene sulfide derivatives of the general formula (4), such as 2-amino-2'-carboxy-phenylene sulfide, 2-amino-4-methoxy-2' -Carboxyl-phenylene sulfide, 2-amino-4-methyl-2'-carboxy-phenylene sulfide, 2-amino-4-phenyl-2'-carboxy-phenylene sulfide, 2-amino-4-acetyl Base-2'-carboxy-phenylene sulfide and 2-amino-2'-carboxy-4'-methoxy-phenylene sulfide. Preference is given to 2-amino-2'-carboxy-phenylene sulfide and 2-amino-2'-carboxy-4'-methoxy-phenylene sulfide.
本发明的制备方法的第3步骤是将通式(4)的2-氨基-2’-羧基-苯硫醚衍生物脱水缩合,制备通式(5)表示的二苯并硫氮衍生物的方法。The third step of the preparation method of the present invention is to dehydrate and condense the 2-amino-2'-carboxy-phenylene sulfide derivatives of the general formula (4) to prepare the dibenzothiazepine represented by the general formula (5) Derivative method.
第3步骤的反应可以无溶剂进行,但优选使用疏水性且对反应为惰性的有机溶剂进行。作为这种有机溶剂的实例,例如甲苯、二甲苯、异丙基苯、苯等芳香族烃类溶剂,氯苯、1,2-二氯苯、1,3-二氯苯、1,4-二氯苯、溴苯、1,2-二溴苯、1,3-二溴苯、1,4-二溴苯等芳香族卤化物类溶剂,环己烷、环庚烷、环辛烷等环状烃类溶剂或乙酸乙酯、乙酸丁酯、丁酸甲酯、丁酸乙酯、丁酸丁酯等脂肪族酯类溶剂等。特别优选甲苯、二甲苯、异丙基苯和1,2-二氯苯。The reaction in the third step can be performed without a solvent, but it is preferably performed using a hydrophobic organic solvent inert to the reaction. Examples of such organic solvents include aromatic hydrocarbon solvents such as toluene, xylene, cumene, and benzene, chlorobenzene, 1,2-dichlorobenzene, 1,3-dichlorobenzene, 1,4- Dichlorobenzene, bromobenzene, 1,2-dibromobenzene, 1,3-dibromobenzene, 1,4-dibromobenzene and other aromatic halide solvents, cyclohexane, cycloheptane, cyclooctane, etc. Cyclic hydrocarbon solvents or aliphatic ester solvents such as ethyl acetate, butyl acetate, methyl butyrate, ethyl butyrate, and butyl butyrate, etc. Particular preference is given to toluene, xylene, cumene and 1,2-dichlorobenzene.
对于第3步骤中使用的溶剂的用量没有特别的限定,溶剂的体积相对于通式(4)的2-氨基-2’-羧基-苯硫醚衍生物的重量的比(W/V%)优选为3%以上,特别优选4~40%范围的量。另外,为了提高第3步骤中的反应速度和转化率,也可以使用Dean-Stark装置进行共沸脱水操作(除去生成的水,同时进行回流的操作)。第3步骤的反应温度只要在所用有机溶剂的沸点以下即可,没有特别的限定,优选100℃~200℃范围的温度。For the consumption of the solvent used in the 3rd step is not particularly limited, the volume of solvent is relative to the ratio (W/V%) of the weight of the 2-amino-2'-carboxy-phenylene sulfide derivative of general formula (4) It is preferably 3% or more, particularly preferably in the range of 4 to 40%. In addition, in order to increase the reaction rate and conversion rate in the third step, an azeotropic dehydration operation (operation in which reflux is performed while removing generated water) can also be performed using a Dean-Stark apparatus. The reaction temperature in the third step is not particularly limited as long as it is not higher than the boiling point of the organic solvent used, but a temperature in the range of 100°C to 200°C is preferable.
第3步骤中得到的通式(5)的二苯并硫氮衍生物的化学结构由通式(4)的2-氨基-2’-羧基-苯硫醚衍生物的化学结构确定。作为通式(5)的二苯并硫氮衍生物,例如二苯并〔b,f〕〔1,4〕硫氮-11-酮、8-甲基-二苯并〔b,f〕〔1,4〕硫氮-11-酮、8-苯基-二苯并〔b,f〕〔1,4〕硫氮-11-酮、8-甲氧基-二苯并〔b,f〕〔1,4〕硫氮-11-酮和2-甲氧基-二苯并〔b,f〕〔1,4〕硫氮-11-酮。优选二苯并〔b,f〕〔1,4〕硫氮-11-酮以及2-甲氧基-二苯并〔b,f〕〔1,4〕硫氮-11-酮。The dibenzothiazepine of general formula (5) obtained in the 3rd step The chemical structure of the derivative is determined by the chemical structure of the 2-amino-2'-carboxy-phenylene sulfide derivative of the general formula (4). Dibenzothiazepine as general formula (5) Derivatives such as dibenzo[b,f][1,4]thiazepine -11-one, 8-methyl-dibenzo[b,f][1,4]sulfur -11-one, 8-phenyl-dibenzo[b,f][1,4]sulfur -11-one, 8-methoxy-dibenzo[b,f][1,4]sulfur -11-one and 2-methoxy-dibenzo[b,f][1,4]sulfur- 11-keto. Preferably dibenzo[b,f][1,4]sulfur -11-one and 2-methoxy-dibenzo[b,f][1,4]sulfur -11-one.
第3步骤生成的通式(5)的二苯并硫氮衍生物的回收可以利用冷却反应混合物使二苯并硫氮衍生物的晶体析出的方法容易地实施。因此,通过过滤该晶体可以得到高纯度的二苯并硫氮衍生物。有必要进一步精制时,可以进行重结晶,或采用柱色谱法。或者也可以利用在使反应混合物析出晶体之前,加入碱性水溶液,分离水层后,进行冷却,使二苯并硫氮衍生物结晶的方法。作为配制该操作中使用的碱性水溶液时使用的碱性化合物的实例,例如碳酸氢钠、碳酸钠、碳酸钾、氢氧化钠和氢氧化钾。碱性水溶液中碱性化合物的浓度优选为0.5~30重量%的范围。另外,碱性水溶液的用量没有特别的限定,优选相对于第3步骤的产物(通式(5)的二苯并硫氮衍生物)以0.05~0.4重量倍左右的量使用。The dibenzothiazepine of the general formula (5) that the 3rd step generates Derivatives can be recovered by cooling the reaction mixture to make dibenzothiazepine The method of crystallization of the derivative is easily carried out. Therefore, high-purity dibenzothiazepine can be obtained by filtering the crystal derivative. When further purification is necessary, recrystallization or column chromatography can be used. Or it can also be used to add an alkaline aqueous solution before the reaction mixture is crystallized, and after the water layer is separated, it is cooled to make dibenzothiazepine Method of Derivative Crystallization. As examples of the basic compound used when preparing the basic aqueous solution used in this operation, there are, for example, sodium bicarbonate, sodium carbonate, potassium carbonate, sodium hydroxide and potassium hydroxide. The concentration of the basic compound in the alkaline aqueous solution is preferably in the range of 0.5 to 30% by weight. In addition, the amount of alkaline aqueous solution is not particularly limited, preferably with respect to the product of the 3rd step (dibenzothiazepine of general formula (5) Derivatives) are used in an amount of about 0.05 to 0.4 times by weight.
本发明的优选方式如下所述。Preferred embodiments of the present invention are as follows.
(1)通式(1)的硝基苯衍生物为2-氯硝基苯或2-溴硝基苯。(1) The nitrobenzene derivative of the general formula (1) is 2-chloronitrobenzene or 2-bromonitrobenzene.
(2)通式(2)的硫代水杨酸衍生物为硫代水杨酸或5-甲氧基硫代水杨酸。(2) The thiosalicylic acid derivative of the general formula (2) is thiosalicylic acid or 5-methoxythiosalicylic acid.
(3)本发明的二苯并硫氮衍生物的制备方法的第1步骤中,使用从碳酸钾、氢氧化钠和甲醇钠中选择的碱。(3) dibenzothiazepine of the present invention In the first step of the production method of the derivative, a base selected from potassium carbonate, sodium hydroxide and sodium methoxide is used.
(4)通式(3)的2-硝基-2’-羧基-苯硫醚衍生物为2-硝基-2’-羧基-苯硫醚或2-硝基-2’-羧基-4’-甲氧基-苯硫醚。(4) The 2-nitro-2'-carboxy-phenylene sulfide derivative of the general formula (3) is 2-nitro-2'-carboxy-phenylene sulfide or 2-nitro-2'-carboxy-4 '-methoxy-phenylene sulfide.
(5)本发明的二苯并硫氮衍生物的制备方法的第1步骤中,使用N,N-二甲基甲酰胺或甲醇作为反应溶剂。(5) Dibenzothiazepine of the present invention In the first step of the preparation method of the derivative, N,N-dimethylformamide or methanol is used as a reaction solvent.
(6)本发明的二苯并硫氮衍生物的制备方法的第2步骤的还原反应中,使用兰尼镍作为还原剂,使用甲醇或正丁醇作为溶剂。(6) Dibenzothiazepine of the present invention In the reduction reaction in the second step of the production method of the derivative, Raney nickel is used as a reducing agent, and methanol or n-butanol is used as a solvent.
(7)本发明的二苯并硫氮衍生物的制备方法的第2步骤的还原反应中,使用硫酸亚铁·7水合物作为还原剂,使用氨水溶液作为溶剂。(7) Dibenzothiazepine of the present invention In the reduction reaction in the second step of the production method of the derivative, ferrous sulfate heptahydrate is used as a reducing agent, and an aqueous ammonia solution is used as a solvent.
(8)本发明的二苯并硫氮衍生物的制备方法的第2步骤的还原反应在Pd/C、Pd/硫酸钡或氧化铂中任意一种还原催化剂存在下,使用甲醇或乙醇作为溶剂进行。(8) Dibenzothiazepine of the present invention The reduction reaction in the second step of the preparation method of the derivative is carried out in the presence of any reduction catalyst selected from Pd/C, Pd/barium sulfate or platinum oxide, using methanol or ethanol as a solvent.
(9)通式(4)的2-氨基-2’-羧基-苯硫醚衍生物为2-氨基-2’-羧基-苯硫醚、2-氨基-2’-羧基-4’-甲氧基-苯硫醚或2-甲氧基-二苯并〔b,f〕〔1,4〕硫氮-11-酮。(9) 2-amino-2'-carboxy-phenylene sulfide derivatives of general formula (4) are 2-amino-2'-carboxy-phenylene sulfide, 2-amino-2'-carboxy-4'-methanol Oxy-phenylene sulfide or 2-methoxy-dibenzo[b,f][1,4]sulfur -11-one.
(10)通式(5)表示的二苯并硫氮衍生物为二苯并〔b,f〕〔1,4〕硫氮-11-酮或2-甲氧基-二苯并〔b,f〕〔1,4〕硫氮-11-酮。(10) Dibenzothiazepine represented by general formula (5) Derivatives are dibenzo[b,f][1,4]sulfur -11-one or 2-methoxy-dibenzo[b,f][1,4]sulfur -11-one.
(11)作为第1步骤反应原料的通式(1)的硝基苯衍生物,使用2-氯硝基苯或2-溴硝基苯;另外,作为通式(2)的硫代水杨酸衍生物,使用硫代水杨酸或5-甲氧基硫代水杨酸;作为碱,使用碳酸钾;作为溶剂,使用N,N-二甲基甲酰胺;制备作为通式(3)的2-硝基-2’-羧基-苯硫醚衍生物的2-硝基-2’-羧基苯硫醚或2-硝基-2’-羧基-4’-甲氧基苯硫醚。(11) As the nitrobenzene derivative of the general formula (1) as the first step reaction raw material, use 2-chloronitrobenzene or 2-bromonitrobenzene; in addition, as the thiosalicylate of the general formula (2) Acid derivative, use thiosalicylic acid or 5-methoxy thiosalicylic acid; As base, use potassium carbonate; As solvent, use N,N-dimethylformamide; Prepare as general formula (3) 2-nitro-2'-carboxyphenylene sulfide or 2-nitro-2'-carboxy-4'-methoxyphenylene sulfide derivatives.
(12)作为第2步骤的反应原料,使用2-硝基-2’-羧基-苯硫醚或2-硝基-2’-羧基-4’-甲氧基-苯硫醚,在铂、钯或它们的化合物存在下用氢气将其还原,制备作为通式(4)的2-氨基-2’-羧基-苯硫醚衍生物的2-氨基-2’-羧基-苯硫醚或2-氨基-2’-羧基-4’-甲氧基-苯硫醚。(12) As the reaction raw material of the second step, use 2-nitro-2'-carboxy-phenylene sulfide or 2-nitro-2'-carboxy-4'-methoxy-phenylene sulfide in platinum, In the presence of palladium or their compounds, it is reduced with hydrogen to prepare 2-amino-2'-carboxy-phenylene sulfide or 2-amino-2'-carboxy-phenylene sulfide derivatives as general formula (4). -amino-2'-carboxy-4'-methoxy-phenylene sulfide.
(13)作为第3步骤的反应原料,使用2-氨基-2’-羧基-苯硫醚或2-氨基-2’-羧基-4’-甲氧基-苯硫醚,制备作为通式(5)的二苯并硫氮衍生物的二苯并〔b,f〕〔1,4〕硫氮-11-酮或2-甲氧基-二苯并〔b,f〕〔1,4〕硫氮-11-酮。(13) As the reaction raw material of the 3rd step, use 2-amino-2'-carboxy-phenylene sulfide or 2-amino-2'-carboxy-4'-methoxyl-phenylene sulfide to prepare as general formula ( 5) Dibenzothiazepine Derivatives of dibenzo[b,f][1,4]thiazepine -11-one or 2-methoxy-dibenzo[b,f][1,4]sulfur -11-one.
以下,结合本发明的实施例和比较例更详细地说明本发明的制备方法,但是本发明并不受这些实施例的限定。Hereinafter, the preparation method of the present invention will be described in more detail with reference to the examples and comparative examples of the present invention, but the present invention is not limited by these examples.
〔实施例1〕[Example 1]
将2-氯硝基苯94.5g(0.60摩尔)和碳酸钾159.0g(1.15摩尔)溶解于N,N-二甲基甲酰胺120mL中。在得到的N,N-二甲基甲酰胺溶液中,滴加将硫代水杨酸77.1g(0.50摩尔)溶解于N,N-二甲基甲酰胺120mL得到的溶液,在70℃下搅拌6小时使之反应。向得到的反应液中加入水800mL和乙酸乙酯700mL。向分离出的水层中加入冰400g和浓盐酸194mL,将水层的pH调解为酸性后,在室温下将该溶液搅拌1小时。过滤、干燥析出的晶体,得到黄色粉末状2-硝基-2’-羧基-苯硫醚134.0g(0.49摩尔)。(相对于硫代水杨酸的收率:98%)94.5 g (0.60 mol) of 2-chloronitrobenzene and 159.0 g (1.15 mol) of potassium carbonate were dissolved in 120 mL of N,N-dimethylformamide. To the obtained N,N-dimethylformamide solution, a solution obtained by dissolving 77.1 g (0.50 mol) of thiosalicylic acid in 120 mL of N,N-dimethylformamide was added dropwise, and stirred at 70°C Allow to react for 6 hours. To the obtained reaction liquid were added 800 mL of water and 700 mL of ethyl acetate. 400 g of ice and 194 mL of concentrated hydrochloric acid were added to the separated aqueous layer to adjust the pH of the aqueous layer to acidic, and the solution was stirred at room temperature for 1 hour. The precipitated crystals were filtered and dried to obtain 134.0 g (0.49 mol) of 2-nitro-2'-carboxy-phenylene sulfide as a yellow powder. (yield relative to thiosalicylic acid: 98%)
1H-NMR(DMSO-d6):δ 1 H-NMR (DMSO-d 6 ): δ
7.1~8.3(m,8H)、13.1~13.5(br,1H)7.1~8.3(m, 8H), 13.1~13.5(br, 1H)
〔实施例2〕[Example 2]
将2-氯硝基苯94.5g(0.60摩尔)和碳酸钾159.0g(1.15摩尔)溶解于N,N-二甲基甲酰胺120mL中。在得到的N,N-二甲基甲酰胺溶液中,滴加将硫代水杨酸77.1g(0.50摩尔)溶解于N,N-二甲基甲酰胺120mL得到的溶液,在70℃下搅拌6小时使之反应。向得到的反应液中加入水200mL和浓盐酸194mL,将水层的pH调解为酸性后,在室温下将该溶液搅拌1小时。过滤、干燥析出的晶体,得到黄色粉末状2-硝基-2’-羧基-苯硫醚123.0g(0.45摩尔)。(相对于硫代水杨酸的收率:90%)94.5 g (0.60 mol) of 2-chloronitrobenzene and 159.0 g (1.15 mol) of potassium carbonate were dissolved in 120 mL of N,N-dimethylformamide. To the obtained N,N-dimethylformamide solution, a solution obtained by dissolving 77.1 g (0.50 mol) of thiosalicylic acid in 120 mL of N,N-dimethylformamide was added dropwise, and stirred at 70°C Allow to react for 6 hours. 200 mL of water and 194 mL of concentrated hydrochloric acid were added to the obtained reaction liquid to adjust the pH of the aqueous layer to acidic, and the solution was stirred at room temperature for 1 hour. The precipitated crystals were filtered and dried to obtain 123.0 g (0.45 mol) of 2-nitro-2'-carboxy-phenylene sulfide as a yellow powder. (yield relative to thiosalicylic acid: 90%)
〔实施例3〕[Example 3]
除用2-溴硝基苯代替2-氯硝基苯,将其用量改变为121.2g(0.60摩尔)以外,进行与实施例1同样的操作,得到2-硝基-2’-羧基-苯硫醚134.0g(0.49摩尔)。(相对于硫代水杨酸的收率:98%)Except that 2-bromonitrobenzene is used to replace 2-chloronitrobenzene, and its amount is changed to 121.2g (0.60 moles), the same operation as in Example 1 is carried out to obtain 2-nitro-2'-carboxy-benzene Thioether 134.0 g (0.49 mol). (yield relative to thiosalicylic acid: 98%)
〔实施例4〕[Example 4]
除用5-甲氧基硫代水杨酸代替硫代水杨酸,将其用量改变为93.8g(0.50摩尔)以外,进行与实施例1同样的操作,得到2-硝基-2’-羧基-4’-甲氧基-苯硫醚137.3g(0.45摩尔)。(相对于5-甲氧基硫代水杨酸的收率:90%)。熔点:185~187℃Except that thiosalicylic acid is replaced with 5-methoxythiosalicylic acid, and its dosage is changed to 93.8g (0.50 moles), the same operation as in Example 1 is carried out to obtain 2-nitro-2'- Carboxy-4'-methoxy-phenylene sulfide 137.3 g (0.45 mol). (Yield relative to 5-methoxythiosalicylic acid: 90%). Melting point: 185~187℃
〔实施例5〕[Example 5]
除将溶剂从N,N-二甲基甲酰胺改变为甲醇,并将反应温度和时间改变为64℃和2小时以外,进行与实施例1同样的操作,得到2-硝基-2’-羧基-苯硫醚131.3g(0.48摩尔)。(相对于硫代水杨酸的收率:96%)Except that the solvent was changed from N,N-dimethylformamide to methanol, and the reaction temperature and time were changed to 64°C and 2 hours, the same operation as in Example 1 was carried out to obtain 2-nitro-2'- Carboxy-phenylene sulfide 131.3 g (0.48 mol). (yield relative to thiosalicylic acid: 96%)
〔实施例6〕[Example 6]
除将碳酸钾改变为氢氧化钠,将其用量改变为46.0g(1.15摩尔)以外,进行与实施例5同样的操作,得到2-硝基-2’-羧基-苯硫醚130.0g(0.47摩尔)。(相对于硫代水杨酸的收率:94%)Except that potassium carbonate is changed into sodium hydroxide, and its consumption is changed to 46.0g (1.15 mole), carry out the same operation with embodiment 5, obtain 2-nitro-2'-carboxy-phenylene sulfide 130.0g (0.47 Moore). (yield relative to thiosalicylic acid: 94%)
〔实施例7〕[Example 7]
除将碳酸钾改变为甲醇钠,将其用量改变为62.1g(1.15摩尔),并将反应时间改变为5小时以外,进行与实施例5同样的操作,得到2-硝基-2’-羧基-苯硫醚131.8g(0.48摩尔)。(相对于硫代水杨酸的收率:96%)Except that potassium carbonate is changed to sodium methylate, its consumption is changed to 62.1g (1.15 moles), and the reaction time is changed to 5 hours, the same operation as in Example 5 is carried out to obtain 2-nitro-2'-carboxyl - Phenylsulfide 131.8 g (0.48 mol). (yield relative to thiosalicylic acid: 96%)
〔实施例8〕[Example 8]
除预先在反应溶液中添加碘化钾3.9g(0.02摩尔)以外,进行与实施例7同样的操作,得到2-硝基-2’-羧基-苯硫醚133.8g(0.49摩尔)。(相对于硫代水杨酸的收率:97%)Except having previously added 3.9 g (0.02 mol) of potassium iodide to the reaction solution, the same operation as in Example 7 was carried out to obtain 133.8 g (0.49 mol) of 2-nitro-2'-carboxy-phenylene sulfide. (yield relative to thiosalicylic acid: 97%)
〔实施例9〕[Example 9]
向300mL的高压釜中加入兰尼镍(作为50%合金,Ni量为4g)、按照实施例1的方法得到的2-硝基-2’-羧基-苯硫醚13.8g(0.05摩尔)和甲醇100mL,调解至氢压为20个大气压后,在室温下搅拌5小时使之反应。过滤得到的反应溶液,减压浓缩滤液,得到无色粉末状2-氨基-2’-羧基-苯硫醚11.3g(0.046摩尔)。(相对于2-硝基-2’-羧基-苯硫醚的收率:92%)In the autoclave of 300mL, add Raney nickel (as 50% alloy, Ni amount is 4g), 13.8g (0.05 mole) of 2-nitro-2'-carboxy-phenylene sulfide obtained according to the method for embodiment 1 and Methanol 100mL was adjusted to a hydrogen pressure of 20 atmospheres, and stirred at room temperature for 5 hours to react. The resulting reaction solution was filtered, and the filtrate was concentrated under reduced pressure to obtain 11.3 g (0.046 mol) of 2-amino-2'-carboxy-phenylene sulfide as a colorless powder. (yield relative to 2-nitro-2'-carboxy-phenylene sulfide: 92%)
1H-NMR(DMSO-d6):δ 1 H-NMR (DMSO-d 6 ): δ
5.0~5.9(br,2H)、6.5~8.1(m,8H)、12.8~13.5(br,1H)5.0~5.9(br, 2H), 6.5~8.1(m, 8H), 12.8~13.5(br, 1H)
〔实施例10〕[Example 10]
将兰尼镍(作为50%合金,Ni量为1g)以及按照实施例1的方法得到的2-硝基-2’-羧基-苯硫醚4.0g(14.5毫摩尔)悬浊于正丁醇50mL中。向得到的正丁醇悬浊液中通入氢,同时在100℃下搅拌15小时使之反应。过滤得到的反应悬浊液,减压浓缩滤液,得到无色粉末状2-氨基-2’-羧基-苯硫醚3.24g(13.2毫摩尔)。(相对于2-硝基-2’-羧基-苯硫醚的收率:91%)Suspend 4.0 g (14.5 mmoles) of Raney nickel (as a 50% alloy, the amount of Ni is 1 g) and 2-nitro-2'-carboxy-phenylene sulfide obtained by the method of Example 1 in n-butanol 50mL. While bubbling hydrogen into the obtained n-butanol suspension, stirring was carried out at 100° C. for 15 hours to allow a reaction. The resulting reaction suspension was filtered, and the filtrate was concentrated under reduced pressure to obtain 3.24 g (13.2 mmol) of 2-amino-2'-carboxy-phenylene sulfide as a colorless powder. (yield relative to 2-nitro-2'-carboxy-phenylene sulfide: 91%)
〔实施例11〕[Example 11]
将实施例1得到的2-硝基-2’-羧基-苯硫醚2.75g(10.0毫摩尔)溶解于浓氨水溶液(氨浓度=28重量%)40mL中。向得到的氨混合液中滴加将硫酸亚铁7水合物21.6g(77.8毫摩尔)溶于水70mL得到的溶液,在80℃下加热10分钟使之反应。将得到的反应溶液冷却至室温后,过滤,将滤液减压浓缩至30mL,加入乙酸乙酯70mL和醋酸2mL。用无水硫酸镁使分离出的有机层干燥,过滤除去干燥剂后,减压浓缩滤液,得到无色粉末状的2-氨基-2’-羧基-苯硫醚2.33g(9.50毫摩尔)。(相对于2-硝基-2’-羧基-苯硫醚的收率:95%)2.75 g (10.0 mmol) of 2-nitro-2'-carboxy-phenylene sulfide obtained in Example 1 was dissolved in 40 mL of concentrated ammonia solution (ammonia concentration = 28% by weight). A solution obtained by dissolving 21.6 g (77.8 mmol) of ferrous sulfate heptahydrate in 70 mL of water was added dropwise to the obtained ammonia mixture, followed by heating at 80° C. for 10 minutes to allow a reaction. After cooling the obtained reaction solution to room temperature, it was filtered, and the filtrate was concentrated to 30 mL under reduced pressure, and 70 mL of ethyl acetate and 2 mL of acetic acid were added. The separated organic layer was dried over anhydrous magnesium sulfate, and the desiccant was removed by filtration, and the filtrate was concentrated under reduced pressure to obtain 2.33 g (9.50 mmol) of 2-amino-2'-carboxy-phenylene sulfide as a colorless powder. (yield relative to 2-nitro-2'-carboxy-phenylene sulfide: 95%)
〔实施例12〕[Example 12]
除使用按照实施例4的方法得到的2-硝基-2’-羧基-4’-甲氧基-苯硫醚15.2g(0.05摩尔)以外,进行与实施例10同样的操作,得到无色粉末状2-氨基-2’-羧基-4’-甲氧基-苯硫醚12.7g(0.046摩尔)。(相对于2-硝基-2’-羧基-4’-甲氧基-苯硫醚的收率:92%)Except using 15.2 g (0.05 mol) of 2-nitro-2'-carboxy-4'-methoxy-phenylene sulfide obtained according to the method of Example 4, the same operation as in Example 10 was performed to obtain a colorless 12.7 g (0.046 mol) of powdery 2-amino-2'-carboxy-4'-methoxy-phenylene sulfide. (yield relative to 2-nitro-2'-carboxy-4'-methoxy-phenylene sulfide: 92%)
熔点:150~151℃Melting point: 150~151℃
〔实施例13〕[Example 13]
向300mL的高压釜中填充1.37g的Pd(5wt%)/C、按照实施例1的方法得到的2-硝基-2’-羧基-苯硫醚13.7g(0.05摩尔)以及甲醇95mL,将氢压调解至10个大气压后,在25℃下搅拌6小时,进行加氢反应。过滤反应混合物,减压浓缩滤液,得到无色粉末状2-氨基-2’-羧基-苯硫醚11.7g(0.048摩尔)。(相对于2-硝基-2’-羧基-苯硫醚的收率:95%)Fill 1.37g of Pd (5wt%)/C, 13.7g (0.05 moles) of 2-nitro-2'-carboxy-phenylene sulfide obtained according to the method of Example 1 and 95mL of methanol in a 300mL autoclave, After the hydrogen pressure was adjusted to 10 atmospheres, the mixture was stirred at 25°C for 6 hours to carry out hydrogenation reaction. The reaction mixture was filtered, and the filtrate was concentrated under reduced pressure to obtain 11.7 g (0.048 mol) of 2-amino-2'-carboxy-phenylene sulfide as a colorless powder. (yield relative to 2-nitro-2'-carboxy-phenylene sulfide: 95%)
熔点:150~151℃Melting point: 150~151℃
〔实施例14〕[Example 14]
除将反应温度改变为50℃,将反应时间改变为4小时以外,进行与实施例13同样的操作,得到2-氨基-2’-羧基-苯硫醚12.0g(0.049摩尔)。(相对于2-硝基-2’-羧基-苯硫醚的收率:98%)Except that the reaction temperature was changed to 50°C and the reaction time was changed to 4 hours, the same operation as in Example 13 was carried out to obtain 12.0 g (0.049 mol) of 2-amino-2'-carboxy-phenylene sulfide. (yield relative to 2-nitro-2'-carboxy-phenylene sulfide: 98%)
〔实施例15〕[Example 15]
除将1.37g的Pd(5wt%)/C改变为2.91g的Pd(5wt%)/C(含水率:52.9wt%)以外,进行与实施例14同样的操作,得到2-氨基-2’-羧基-苯硫醚11.9g(0.049摩尔)。(相对于2-硝基-2’-羧基-苯硫醚的收率:97%)Except that 1.37g of Pd(5wt%)/C was changed to 2.91g of Pd(5wt%)/C (water content: 52.9wt%), the same operation as in Example 14 was carried out to obtain 2-amino-2' -Carboxy-phenylene sulfide 11.9 g (0.049 mol). (yield relative to 2-nitro-2'-carboxy-phenylene sulfide: 97%)
〔实施例16〕[Example 16]
除将甲醇的用量改变为50mL,并将反应时间改变为6小时以外,进行与实施例14同样的操作,得到2-氨基-2’-羧基-苯硫醚11.9g(0.049摩尔)。(相对于2-硝基-2’-羧基-苯硫醚的收率:97%)Except that the amount of methanol used was changed to 50 mL and the reaction time was changed to 6 hours, the same operation as in Example 14 was carried out to obtain 11.9 g (0.049 mol) of 2-amino-2'-carboxy-phenylene sulfide. (yield relative to 2-nitro-2'-carboxy-phenylene sulfide: 97%)
〔实施例17〕[Example 17]
除将甲醇的用量改变为180mL,并将反应时间改变为6小时以外,进行与实施例14同样的操作,得到2-氨基-2’-羧基-苯硫醚11.2g(0.046摩尔)。(相对于2-硝基-2’-羧基-苯硫醚的收率:91%)Except that the amount of methanol used was changed to 180 mL and the reaction time was changed to 6 hours, the same operation as in Example 14 was carried out to obtain 11.2 g (0.046 mol) of 2-amino-2'-carboxy-phenylene sulfide. (yield relative to 2-nitro-2'-carboxy-phenylene sulfide: 91%)
〔实施例18〕[Example 18]
除将甲醇改变为乙醇以外,进行与实施例14同样的操作,得到2-氨基-2’-羧基-苯硫醚11.2g(0.046摩尔)。(相对于2-硝基-2’-羧基-苯硫醚的收率:92%)Except for changing methanol to ethanol, the same operation as in Example 14 was carried out to obtain 11.2 g (0.046 mol) of 2-amino-2'-carboxy-phenylene sulfide. (yield relative to 2-nitro-2'-carboxy-phenylene sulfide: 92%)
〔实施例19〕[Example 19]
除将1.37g的Pd(5wt%)/C改变为640mg的氧化铂(PtO2)以外,进行与实施例14同样的操作,得到2-氨基-2’-羧基-苯硫醚10.8g(0.044摩尔)。(相对于2-硝基-2’-羧基-苯硫醚的收率:88%)Except that 1.37g of Pd (5wt%)/C was changed to 640mg of platinum oxide (PtO 2 ), the same operation as in Example 14 was performed to obtain 10.8g of 2-amino-2'-carboxy-phenylene sulfide (0.044 Moore). (yield relative to 2-nitro-2'-carboxy-phenylene sulfide: 88%)
〔实施例20〕[Example 20]
除使用按照实施例4的方法得到的2-硝基-2’-羧基-4’-甲氧基-苯硫醚15.2g(0.05摩尔)以外,进行与实施例14同样的操作,得到2-氨基-2’-羧基-4’-甲氧基-苯硫醚12.7g(0.046摩尔)。(相对于2-硝基-2’-羧基-4’-甲氧基-苯硫醚的收率:92%)Except using 15.2 g (0.05 moles) of 2-nitro-2'-carboxy-4'-methoxy-phenylene sulfide obtained according to the method of Example 4, the same operation as in Example 14 was carried out to obtain 2- Amino-2'-carboxy-4'-methoxy-phenylene sulfide 12.7 g (0.046 mol). (yield relative to 2-nitro-2'-carboxy-4'-methoxyl-phenylene sulfide: 92%)
〔实施例21〕[Example 21]
将按照实施例9的方法得到的2-氨基-2’-羧基-苯硫醚24.5g(0.10摩尔)溶解于甲苯300mL中。使得到的甲苯溶液回流20小时进行反应。将得到的反应溶液冷却至室温后,过滤析出的晶体。将得到的过滤物干燥,得到二苯并〔b,f〕〔1,4〕硫氮-11-酮的无色针状晶体15.7g(0.069摩尔)。(相对于2-氨基-2’-羧基-苯硫醚的收率:69%)。熔点:259~260℃24.5 g (0.10 mol) of 2-amino-2'-carboxy-phenylene sulfide obtained by the method of Example 9 was dissolved in 300 mL of toluene. The obtained toluene solution was refluxed for 20 hours to perform a reaction. After cooling the obtained reaction solution to room temperature, the precipitated crystals were filtered. The resulting filtrate was dried to give dibenzo[b,f][1,4]sulfur 15.7 g (0.069 mol) of colorless needle crystals of -11-one. (Yield relative to 2-amino-2'-carboxy-phenylene sulfide: 69%). Melting point: 259~260℃
1H-NMR(DMSO-d6):δ 1 H-NMR (DMSO-d 6 ): δ
7.05~7.80(m,8H)、10.7(s,1H)7.05~7.80(m, 8H), 10.7(s, 1H)
〔实施例22〕[Example 22]
将按照实施例9的方法得到的2-氨基-2’-羧基-苯硫醚24.5g(0.10摩尔)溶解于甲苯300mL中。使得到的甲苯溶液进行共沸脱水20小时(使用Dean-Stark装置)同时进行回流使之反应。将得到的反应溶液冷却至室温后,过滤收集析出的晶体。接着,将得到的过滤物干燥,得到二苯并〔b,f〕〔1,4〕硫氮-11-酮的无色针状晶体18.2g(0.080摩尔)。(相对于2-氨基-2’-羧基-苯硫醚的收率:80%)。24.5 g (0.10 mol) of 2-amino-2'-carboxy-phenylene sulfide obtained by the method of Example 9 was dissolved in 300 mL of toluene. The obtained toluene solution was subjected to azeotropic dehydration (using a Dean-Stark apparatus) for 20 hours while being refluxed for reaction. After cooling the obtained reaction solution to room temperature, the precipitated crystals were collected by filtration. Next, the resulting filtrate was dried to obtain dibenzo[b,f][1,4]sulfur 18.2 g (0.080 mol) of colorless needle-like crystals of -11-one. (Yield relative to 2-amino-2'-carboxy-phenylene sulfide: 80%).
〔实施例23〕[Example 23]
除将反应溶剂改变为二甲苯,将反应时间改变为15小时以外,进行与实施例22同样的反应,得到二苯并〔b,f〕〔1,4〕硫氮-11-酮的无色针状晶体22.3g(0.098摩尔)。(相对于2-氨基-2’-羧基-苯硫醚的收率:98%)。Except that the reaction solvent is changed to xylene and the reaction time is changed to 15 hours, the same reaction as in Example 22 is carried out to obtain dibenzo[b,f][1,4]sulfur nitrogen 22.3 g (0.098 mol) of colorless needle crystals of -11-one. (Yield relative to 2-amino-2'-carboxy-phenylene sulfide: 98%).
〔实施例24〕[Example 24]
除将反应溶剂改变为异丙基苯,将反应时间改变为10小时以外,进行与实施例22同样的反应,得到二苯并〔b,f〕〔1,4〕硫氮-11-酮的无色针状晶体22.3g(0.098摩尔)。(相对于2-氨基-2’-羧基-苯硫醚的收率:98%)。Except that the reaction solvent is changed to cumene, and the reaction time is changed to 10 hours, the same reaction as in Example 22 is carried out to obtain dibenzo[b, f][1,4] sulfur nitrogen 22.3 g (0.098 mol) of colorless needle crystals of -11-one. (Yield relative to 2-amino-2'-carboxy-phenylene sulfide: 98%).
〔实施例25〕[Example 25]
将按照实施例14的方法得到的2-氨基-2’-羧基-苯硫醚24.5g(0.10摩尔)溶解于二甲苯300mL中。使得到的二甲苯溶液进行共沸脱水15小时(使用Dean-Stark装置)同时进行回流使之反应。将得到的反应溶液冷却至75℃后,向其中加入饱和碳酸氢钠水溶液240mL,再在75℃下搅拌30分钟。接着,过滤收集析出的晶体。将得到的过滤物干燥,得到二苯并〔b,f〕〔1,4〕硫氮-11-酮的无色针状晶体21.5g(0.095摩尔)。(相对于2-氨基-2’-羧基-苯硫醚的收率:95%)。24.5 g (0.10 mol) of 2-amino-2'-carboxy-phenylene sulfide obtained by the method of Example 14 was dissolved in 300 mL of xylene. The resulting xylene solution was subjected to azeotropic dehydration (using a Dean-Stark apparatus) for 15 hours while being refluxed for reaction. After cooling the obtained reaction solution to 75° C., 240 mL of a saturated aqueous sodium bicarbonate solution was added thereto, followed by stirring at 75° C. for 30 minutes. Next, the precipitated crystals were collected by filtration. The resulting filtrate was dried to give dibenzo[b,f][1,4]sulfur 21.5 g (0.095 mol) of colorless needle crystals of -11-one. (Yield relative to 2-amino-2'-carboxy-phenylene sulfide: 95%).
〔实施例26〕[Example 26]
除将饱和碳酸氢钠水溶液改变为1N氢氧化钠水溶液,将其用量改变为200mL以外,进行与实施例25同样的反应,得到二苯并〔b,f〕〔1,4〕硫氮-11-酮的无色针状晶体21.1g(0.093摩尔)。(相对于2-氨基-2’-羧基-苯硫醚的收率:93%)。Except that the saturated sodium bicarbonate aqueous solution is changed to 1N sodium hydroxide aqueous solution, and its dosage is changed to 200mL, the same reaction as in Example 25 is carried out to obtain dibenzo[b,f][1,4]sulfur nitrogen 21.1 g (0.093 mol) of colorless needle crystals of -11-one. (Yield relative to 2-amino-2'-carboxy-phenylene sulfide: 93%).
〔实施例27〕[Example 27]
除将反应溶剂改变为异丙基苯,将反应时间改变为10小时以外,进行与实施例25同样的反应,得到二苯并〔b,f〕〔1,4〕硫氮-11-酮的无色针状晶体22.0g(0.097摩尔)。(相对于2-氨基-2’-羧基-苯硫醚的收率:97%)。Except that the reaction solvent is changed to cumene, and the reaction time is changed to 10 hours, the same reaction as in Example 25 is carried out to obtain dibenzo[b, f][1,4] sulfur nitrogen 22.0 g (0.097 mol) of colorless needle crystals of -11-one. (Yield relative to 2-amino-2'-carboxy-phenylene sulfide: 97%).
〔实施例28〕[Example 28]
使用按照实施例12的方法得到的2-氨基-2’-羧基-4’-甲氧基-苯硫醚27.5g(0.10摩尔),进行与实施例23同样的反应,得到2-甲氧基-二苯并〔b,f〕〔1,4〕硫氮-11-酮的无色针状晶体23.6g(0.092摩尔)。(相对于2-氨基-4-甲氧基-2’-羧基-苯硫醚的收率:92%)。熔点:220~223℃Using 27.5 g (0.10 moles) of 2-amino-2'-carboxy-4'-methoxy-phenylene sulfide obtained according to the method of Example 12, the same reaction as in Example 23 was carried out to obtain 2-methoxy -Dibenzo[b,f][1,4]sulfur 23.6 g (0.092 mol) of colorless needle crystals of -11-one. (Yield relative to 2-amino-4-methoxy-2'-carboxy-phenylene sulfide: 92%). Melting point: 220~223℃
工业实用性Industrial Applicability
按照本发明的二苯并硫氮的制备方法,通过使硝基苯衍生物与硫代水杨酸衍生物反应,生成2-硝基-2’-羧基-苯硫醚衍生物后,将该产物还原,生成2-氨基-2’-羧基-苯硫醚衍生物,接着将该产物脱水缩合,能够以高收率而且采用简单的操作制备作为药品的中间体实用性高的通式(5)表示的二苯并硫氮衍生物。Dibenzothiazepine according to the present invention The preparation method of nitrobenzene derivatives is reacted with thiosalicylic acid derivatives to generate 2-nitro-2'-carboxy-phenylene sulfide derivatives, and then the product is reduced to generate 2-amino-2 '-Carboxyl-phenylene sulfide derivatives, followed by dehydration condensation of this product, can produce dibenzothiazepines represented by the general formula (5) with high practicability as intermediates of pharmaceuticals with high yield and simple operation derivative.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2006101003178A CN1872846B (en) | 1999-07-09 | 1999-07-09 | Preparation method of dibenzothiazepine* derivatives |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2006101003178A CN1872846B (en) | 1999-07-09 | 1999-07-09 | Preparation method of dibenzothiazepine* derivatives |
Related Parent Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200610006965A Division CN100577653C (en) | 1999-07-09 | 1999-07-09 | Process for preparing dibenzothiazepine derivatives |
| CNB998168858A Division CN1247556C (en) | 1999-07-09 | 1999-07-09 | Preparation method of dibenzothiazepine derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1872846A CN1872846A (en) | 2006-12-06 |
| CN1872846B true CN1872846B (en) | 2010-06-16 |
Family
ID=37483468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2006101003178A Expired - Fee Related CN1872846B (en) | 1999-07-09 | 1999-07-09 | Preparation method of dibenzothiazepine* derivatives |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1872846B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116987018A (en) * | 2023-07-31 | 2023-11-03 | 武汉世吉药业有限公司 | Preparation method of quetiapine intermediate |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992019607A1 (en) * | 1991-05-02 | 1992-11-12 | The Wellcome Foundation Limited | Dibenzothiazepinthione as antiviral agents |
| CN1073168A (en) * | 1991-10-21 | 1993-06-16 | 盐野义制药株式会社 | Benzothiazepine derivatives |
-
1999
- 1999-07-09 CN CN2006101003178A patent/CN1872846B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992019607A1 (en) * | 1991-05-02 | 1992-11-12 | The Wellcome Foundation Limited | Dibenzothiazepinthione as antiviral agents |
| CN1073168A (en) * | 1991-10-21 | 1993-06-16 | 盐野义制药株式会社 | Benzothiazepine derivatives |
Non-Patent Citations (3)
| Title |
|---|
| Bennett et al..Synthesis of2-Methoxydibenzo[b,f](1,4)-Thiazepin-11(10H)-one-5,5-dioxide.Organic Preparations and Procedures Int.6 6.1974,6(6),287-293. |
| Bennett et al..Synthesis of2-Methoxydibenzo[b,f](1,4)-Thiazepin-11(10H)-one-5,5-dioxide.Organic Preparations and Procedures Int.6 6.1974,6(6),287-293. * |
| Kuti et al.Novel Reactions of Spirosulfurane Precursor Sulfides andSulfoxides.Phosphorus, Sulfur, and Silicon85.1993,85119-127. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1872846A (en) | 2006-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL189161A (en) | Process for preparing a 2-nitro-2'-carboxy-diphenylsulfide derivative | |
| US7671195B2 (en) | Process for preparing dibenzothiazepine compounds | |
| JPWO2001004106A1 (en) | Method for producing dibenzothiazepine derivatives | |
| CN1872846B (en) | Preparation method of dibenzothiazepine* derivatives | |
| CN100577653C (en) | Process for preparing dibenzothiazepine derivatives | |
| JP3865096B2 (en) | Method for producing dibenzothiazepine derivative | |
| JP2011126887A (en) | Method for producing dibenzothiazepine derivative | |
| HK1098142B (en) | Process for producing dibenzothiazepine derivatives | |
| HK1092460B (en) | Process for producing dibenzothiazepine derivatives | |
| PL209897B1 (en) | Process for producing dibenzothiazepine derivatives | |
| MX2008009914A (en) | Process for preparing dibenzothiazepine compounds | |
| CN101400683A (en) | Process for the preparation of olanzapine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1098142 Country of ref document: HK |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1098142 Country of ref document: HK |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100616 Termination date: 20140709 |
|
| EXPY | Termination of patent right or utility model |